CertifiedTide.com
Back to Database

AOD-9604

Also known as: Anti-Obesity Drug 9604, hGH Fragment 176-191

Metabolic
Phase II

AOD-9604 is a modified fragment of human growth hormone specifically engineered to retain hGH's lipolytic (fat-burning) properties while eliminating its mitogenic and diabetogenic effects. It targets adipose tissue directly through a mechanism independent of IGF-1.

Regulatory & Approval Status

Not FDA Approved

Development of AOD-9604 was effectively terminated after a phase 2b obesity trial failed to meet its primary endpoints; it is not FDA-approved and is prohibited by WADA.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.